Skip to main content
Premium Trial:

Request an Annual Quote

NHLBI Opens Resource for Genetic and Clinical Asthma Data

NEW YORK (GenomeWeb News) — The National Heart, Lung, and Blood Institute has expanded its genetic and clinical data collection to include information collected from three asthma research networks, the National Institutes of Health said today.
 
The new project is part of the NHLBI’s SNP Health Association Resource (SHARe), a web-based dataset that provides researchers with free access to data from multiple, large population-based studies such as the Framingham Heart Study.
 
The new asthma component, called the SHARe-Asthma Resource Project (SHARP), includes data on 2,332 people with asthma and 805 families whose DNA was tested for 1 million genetic variations. SHARP also includes clinical data about lung function, allergy status, and respiratory symptoms.
 
The clinical data used in SHARP is being provided by the Childhood Asthma Management Program, the Childhood Asthma Research and Education Network, and the Asthma Clinical Research Network, all of which are funded by NHLBI.
 
The project will enable scientists to link participants’ genetic variations to their lab test results, making it possible to find out more about genetic influence on asthma and other airway diseases.
 
“Expanding the SHARe program to include asthma through the SHARP initiative will greatly expand our understanding of lung disease biology using genetic and genomic technologies,” NHLBI Director Elizabeth Nabel said in a statement.
 
SHARP data is available through the database of Genotypes and Phenotypes, or dbGaP, hosted by the National Center for Biotechnology Information.
 
Affymetrix developed SNP genotyping data for the asthma program under a contract with NHLBI.
 
More information about the new asthma program is available at the NIH’s website.
 

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.